GLUE Financials

Monte Rosa Therapeutics Inc - Financial statements & key metrics

Stock Price

$14.00

Market Cap

$1.56B

P/E Ratio

74.1

EPS

$0.32

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-72.70M

EPS (Diluted)

Balance Sheet Highlights

Total Assets

$438.73M

Total Liabilities

$215.80M

Shareholders Equity

Cash & Equivalents

$224.25M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$42.00M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-258.3%

Net Margin

11.5%

ROE

9.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is GLUE revenue?

View GLUE's income statement for detailed revenue data.

Is GLUE profitable?

GLUE reported a loss of $72.70M in the most recent quarter. The net profit margin is 11.5%.

What is GLUE market cap?

GLUE has a market capitalization of $1.56B, making it a small-cap stock.

Does GLUE have debt?

View GLUE's balance sheet for debt information.

What is GLUE cash flow?

Cash flow data is available in the full financial statements.